PAPER Wu F, Poon WS, Lu G, Wang A, Meng H, Feng L, Li Z, Liu S
SEARCH RESULTS
331395 RESULTS
PAPER Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Neurochem Int. 2009 Dec;55(8):760-7. PubMed: 19647776PAPER Oien DB, Shinogle HE, Moore DS, Moskovitz J
Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells.
J Mol Neurosci. 2009 Nov;39(3):323-32. PubMed: 19653131PAPER Li C, Lutz EA, Slade KM, Ruf RA, Wang GF, Pielak GJ
19F NMR studies of alpha-synuclein conformation and fibrillation.
Biochemistry. 2009 Sep 15;48(36):8578-84. PubMed: 19655784PAPER Chang E, Honson NS, Bandyopadhyay B, Funk KE, Jensen JR, Kim S, Naphade S, Kuret J
Modulation and Detection of Tau Aggregation with Small-Molecule Ligands.
Curr Alzheimer Res. 2009 Oct 1; PubMed: 19663801PAPER Phillips RJ, Walter GC, Ringer BE, Higgs KM, Powley TL
Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.
Exp Neurol. 2009 Nov;220(1):109-19. PubMed: 19664623PAPER Bisaglia M, Tessari I, Mammi S, Bubacco L
Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease.
Neuromolecular Med. 2009;11(4):239-51. PubMed: 19669606PAPER Fournier M, Vitte J, Garrigue J, Langui D, Dullin JP, Saurini F, Hanoun N, Perez-Diaz F, Cornilleau F, Joubert C, Ardila-Osorio H, Traver S, Duchateau R, Goujet-Zalc C, Paleologou K, Lashuel HA, Haass C, Duyckaerts C, Cohen-Salmon C, Kahle PJ, Hamon M, Brice A, Corti O
Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy.
PLoS One. 2009;4(8):e6629. PubMed: 19680561PAPER Tapias V, Cannon JR, Greenamyre JT
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
J Neurosci Res. 2010 Feb 1;88(2):420-7. PubMed: 19681169PAPER Wu B, Liu Q, Duan C, Li Y, Yu S, Chan P, Uéda K, Yang H
Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells.
Acta Histochem. 2011 Jan;113(1):32-5. PubMed: 19683335PAPER Nishioka K, Kefi M, Jasinska-Myga B, Wider C, Vilariño-Güell C, Ross OA, Heckman MG, Middleton LT, Ishihara-Paul L, Gibson RA, Amouri R, Ben Yahmed S, Ben Sassi S, Zouari M, El Euch G, Farrer MJ, Hentati F
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):391-5. PubMed: 19726410PAPER Soehn AS, Franck T, Biskup S, Giaime E, Melle C, Rott R, Cebo D, Kalbacher H, Ott E, Pahnke J, Meitinger T, Krüger R, Gasser T, Berg D, von Eggeling F, Engelender S, da Costa CA, Riess O
Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease.
Neurogenetics. 2010 May;11(2):203-15. PubMed: 19730898PAPER Truong L, Brooks D, Amaral F, Henderson JM, Halliday GM
Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia.
Mov Disord. 2009 Oct 30;24(14):2128-35. PubMed: 19735086PAPER Inzelberg R, Polyniki A
Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia?
J Neurol Sci. 2010 Feb 15;289(1-2):23-6. PubMed: 19740488PAPER Giovannone B, Tsiaras WG, de la Monte S, Klysik J, Lautier C, Karashchuk G, Goldwurm S, Smith RJ
GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling.
Hum Mol Genet. 2009 Dec 1;18(23):4629-39. PubMed: 19744960Current Filters
No filters selected